ENDRA Life Sciences Inc
Price
FilingsNewest: 8-K, Material agreementOct 1 →InsidersNo open-market buys or sales.→HoldersAltium 4.0%Citadel 2.0%Citizens Financial Group Inc/ri 1.9%→Financing →PeersClosest companies: SILO, CNTN, TTRX→
From the filings
Figures
- Net income
- −$5.9Mlast 12 months
- Operating cash flow
- −$5.0Mlast 12 months
- Cash and equivalents
- $1.7Mat the last balance sheet
- Shares outstanding
- 1.5M shareson issue